NCT00317993View on ClinicalTrials.gov

LDL Receptor Under Ezetimibe and Simvastatin

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Healthy Men
Interventions
DRUG

ezetimibe

DRUG

simvastatin

DRUG

ezetimibe plus simvastatin

Trial Locations (1)

50924

Medizinische Klinik II und Poliklinik für Innere Medizin, Cologne

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Cologne

OTHER

NCT00317993 - LDL Receptor Under Ezetimibe and Simvastatin | Biotech Hunter | Biotech Hunter